Page last updated: 2024-10-18

glycine and MPTP Neurotoxicity Syndrome

glycine has been researched along with MPTP Neurotoxicity Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Pu, Y1
Chang, L1
Qu, Y1
Wang, S1
Tan, Y1
Wang, X1
Zhang, J1
Hashimoto, K1
Karunakaran, S1
Diwakar, L1
Saeed, U1
Agarwal, V1
Ramakrishnan, S1
Iyengar, S1
Ravindranath, V1
Schneider, JS1
Tinker, JP1
Van Velson, M1
Giardiniere, M1
Matarredona, ER1
Santiago, M1
Venero, JL1
Cano, J1
Machado, A1

Other Studies

4 other studies available for glycine and MPTP Neurotoxicity Syndrome

ArticleYear
Glyphosate exposure exacerbates the dopaminergic neurotoxicity in the mouse brain after repeated administration of MPTP.
    Neuroscience letters, 2020, 06-21, Volume: 730

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Dopa

2020
Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007, Volume: 21, Issue:9

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Alkynes; Animals; Antioxidants; Antipa

2007
Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys.
    Brain research, 2000, Mar-31, Volume: 860, Issue:1-2

    Topics: Animals; Cognition; Cycloserine; Discrimination, Psychological; Disease Models, Animal; Dizocilpine

2000
Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction.
    Journal of neurochemistry, 2001, Volume: 76, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzoates; Brain-Derived Neurotrophic Factor;

2001